{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T14:08:16Z","timestamp":1777039696074,"version":"3.51.4"},"reference-count":166,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,16]],"date-time":"2013-10-16T00:00:00Z","timestamp":1381881600000},"content-version":"vor","delay-in-days":107,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.vph.2013.05.001","type":"journal-article","created":{"date-parts":[[2013,5,14]],"date-time":"2013-05-14T03:21:27Z","timestamp":1368501687000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["Defibrotide: Properties and clinical use of an old\/new drug"],"prefix":"10.1016","volume":"59","author":[{"given":"R.","family":"Pescador","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Capuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Fulgenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.E.","family":"Ferrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2013.05.001_bb0005","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1161\/01.CIR.95.3.662","article-title":"l-arginine reduces human monocyte adhesion to vascular endothelium and endothelial expression of cell adhesion molecules","volume":"95","author":"Adams","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2013.05.001_bb0010","first-page":"275","article-title":"Beneficial mechanisms of action of a prostacyclin enhancing agent in splanchnic artery occlusion shock","volume":"60","author":"Aoki","year":"1988","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.vph.2013.05.001_bb0015","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nm0995-869","article-title":"Barriers to xenotransplantation","volume":"1","author":"Bach","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.vph.2013.05.001_bb0020","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1055\/s-0037-1616518","article-title":"Structure and biology of tissue factor pathway inhibitor","volume":"86","author":"Bajaj","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.vph.2013.05.001_bb0025","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","article-title":"Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases","volume":"336","author":"Barnes","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 2","key":"10.1016\/j.vph.2013.05.001_bb0030","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/00005344-199500252-00006","article-title":"Neutrophil activation, tumor necrosis factor, and survival after endotoxic and hemorrhagic shock","volume":"25","author":"Barroso-Aranda","year":"1995","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.vph.2013.05.001_bb0070","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00005344-198603000-00003","article-title":"Defibrotide, an antithrombotic substance that preserves postsynaptic alpha- and beta-adrenergic function in post acute infarcted rabbit hearts","volume":"8","author":"Berti","year":"1986","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.vph.2013.05.001_bb0040","first-page":"657","article-title":"Defibrotide protects rabbit myocardium from ischemia: relationship with the eicosanoid system","volume":"39","author":"Berti","year":"1987","journal-title":"Pol. J. Pharmacol. Pharm."},{"key":"10.1016\/j.vph.2013.05.001_bb0075","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0014-2999(87)90687-X","article-title":"Defibrotide, an antithrombotic substance which prevents myocardial contracture in ischemic rabbit heart","volume":"135","author":"Berti","year":"1987","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.vph.2013.05.001_bb0065","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00005344-198810000-00009","article-title":"Nonsteroidal antiinflammatory drugs aggravate acute myocardial ischemia in the perfused rabbit heart: a role for prostacyclin","volume":"12","author":"Berti","year":"1988","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.vph.2013.05.001_bb0035","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00005344-199011000-00006","article-title":"Production and biologic interactions of prostacyclin and platelet-activating factor in acute myocardial ischemia in the perfused rabbit heart","volume":"16","author":"Berti","year":"1990","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.vph.2013.05.001_bb0050","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0090-6980(90)90099-H","article-title":"Defibrotide, by enhancing prostacyclin generation, prevents endothelin-1 induced contraction in human saphenous veins","volume":"40","author":"Berti","year":"1990","journal-title":"Prostaglandins"},{"key":"10.1016\/j.vph.2013.05.001_bb0045","first-page":"209","article-title":"Effects of defibrotide on prostacyclin release from isolated rabbit kidneys and protection from post-ischemic acute renal failure in vivo","volume":"4","author":"Berti","year":"1991","journal-title":"Eicosanoids"},{"key":"10.1016\/j.vph.2013.05.001_bb0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0049-3848(92)90221-U","article-title":"Defibrotide has antiischemic activity in perfused rabbit hearts, preventing tissue Ca++ overloading","volume":"65","author":"Berti","year":"1992","journal-title":"Thromb. Res."},{"key":"10.1016\/j.vph.2013.05.001_bb0055","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00005344-199308000-00023","article-title":"Nitric oxide and prostacyclin influence coronary vasomotor tone in perfused rabbit heart and modulate endothelin-1 activity","volume":"22","author":"Berti","year":"1993","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.vph.2013.05.001_bb0080","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0014-2999(93)90864-E","article-title":"Defibrotide, a single-stranded polydeoxyribonucleotide acting as an adenosine receptor agonist","volume":"238","author":"Bianchi","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.vph.2013.05.001_bb0085","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/BF00175796","article-title":"Novel mechanism of action of a prostacyclin enhancing agent in haemorrhagic shock","volume":"337","author":"Bitterman","year":"1988","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.vph.2013.05.001_bb0090","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1365-2141.2000.01813.x","article-title":"Increased soluble P-selectin levels following deep venous thrombosis: cause or effect?","volume":"108","author":"Blann","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.vph.2013.05.001_bb0095","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000190340","article-title":"Effect of a new antithrombotic agent (defibrotide) in acute renal failure due to thrombotic microangiopathy","volume":"40","author":"Bonomini","year":"1985","journal-title":"Nephron"},{"key":"10.1016\/j.vph.2013.05.001_bb0100","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1006\/bbrc.1994.1539","article-title":"Isolation and identification of aptamers from defibrotide that act as thrombin antagonists in vitro","volume":"200","author":"Bracht","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.vph.2013.05.001_bb0105","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/pbc.20934","article-title":"Defibrotide for the treatment of hepatic veno-occlusive disease in children","volume":"48","author":"Bulley","year":"2007","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.vph.2013.05.001_bb0110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000159147","article-title":"Endothelial dysfunction in atherosclerosis","volume":"33","author":"Busse","year":"1996","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.vph.2013.05.001_bb0115","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1161\/ATVBAHA.108.177402","article-title":"Tissue factor in coagulation: which? Where? When?","volume":"29","author":"Butenas","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2013.05.001_bb0120","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1161\/01.ATV.19.2.220","article-title":"Oleic acid inhibits endothelial activation: a direct vascular antiatherogenic mechanism of a nutritional component in the mediterranean diet","volume":"19","author":"Carluccio","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2013.05.001_bb0125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0735-1097(97)00189-7","article-title":"Endothelial dysfunction: does it matter? Is it reversible?","volume":"30","author":"Celermajer","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2013.05.001_bb0130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/107602960100700308","article-title":"Tissue factor pathway inhibitor release induced by defibrotide and heparins","volume":"7","author":"Cella","year":"2001","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.vph.2013.05.001_bb0135","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1006\/phrs.2000.0784","article-title":"Anti-inflammatory drugs: new multitarget compounds to face an old problem. The dual inhibition concept","volume":"43","author":"Celotti","year":"2001","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.vph.2013.05.001_bb0140","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/pbc.22841","article-title":"Veno-occlusive disease in pediatric patients affected by Wilms tumor","volume":"57","author":"Cesaro","year":"2011","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.vph.2013.05.001_bb0145","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1006\/bbrc.2001.5361","article-title":"PPARgamma ligands inhibit TNF-alpha-induced LOX-1 expression in cultured endothelial cells","volume":"286","author":"Chiba","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.vph.2013.05.001_bb0150","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1046\/j.1365-2141.2000.02475.x","article-title":"Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study","volume":"111","author":"Chopra","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.vph.2013.05.001_bb0155","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0024-3205(97)01167-3","article-title":"Linkage between inflammation and coagulation: an update on the molecular basis of the crosstalk","volume":"62","author":"Cicala","year":"1998","journal-title":"Life Sci."},{"key":"10.1016\/j.vph.2013.05.001_bb0160","first-page":"98","article-title":"In vitro inhibition by defibrotide of monocyte superoxide anion generation: a possible mechanism for the antithrombotic effect of a polydeoxyribonucleotide-derived drug","volume":"21","author":"Cirillo","year":"1991","journal-title":"Haemostasis"},{"key":"10.1016\/j.vph.2013.05.001_bb0170","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1527-3466.1991.tb00410.x","article-title":"Defibrotide","volume":"9","author":"Coccheri","year":"1991","journal-title":"Cardiovasc. Drug Rev."},{"issue":"Suppl. 1","key":"10.1016\/j.vph.2013.05.001_bb0175","first-page":"9","article-title":"Defibrotide as a possible anti-ischemic drug","volume":"22","author":"Coccheri","year":"1996","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.vph.2013.05.001_bb0165","first-page":"100","article-title":"Effects of defibrotide in patients with chronic deep insufficiency. The PROVEDIS study","volume":"23","author":"Coccheri","year":"2004","journal-title":"Int. Angiol."},{"key":"10.1016\/j.vph.2013.05.001_bb0835","unstructured":"Cook, J.A., Halushka, P.V., 1989. Arachidonic acid metabolism in septic shock, New Horizons ed. Society of Critical Care Medicine, Fullerton."},{"key":"10.1016\/j.vph.2013.05.001_bb0185","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(11)61938-7","article-title":"Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial","volume":"379","author":"Corbacioglu","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.vph.2013.05.001_bb0190","first-page":"3281","article-title":"Prolonged survival of grafted rat hearts by use of defibrotide and cyclosporine","volume":"25","author":"Corsi","year":"1993","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.vph.2013.05.001_bb0195","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/sj.bmt.1703414","article-title":"Defibrotide as a promising treatment for thrombotic thrombocytopenic purpura in patients undergoing bone marrow transplantation","volume":"29","author":"Corti","year":"2002","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.vph.2013.05.001_bb0200","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0952-3278(97)90506-8","article-title":"Leukotriene C4 from vascular endothelium enhances neutrophil adhesiveness","volume":"56","author":"Damtew","year":"1997","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.vph.2013.05.001_bb0205","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2002-23204","article-title":"Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease)","volume":"22","author":"DeLeve","year":"2002","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.vph.2013.05.001_bb0210","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/384039a0","article-title":"The PPARalpha-leukotriene B4 pathway to inflammation control","volume":"384","author":"Devchand","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.vph.2013.05.001_bb0215","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0741-5214(97)70211-8","article-title":"Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis","volume":"25","author":"Downing","year":"1997","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.vph.2013.05.001_bb0220","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/1076029611412367","article-title":"Defibrotide blunts the prothrombotic effect of thalidomide on endothelial cells","volume":"18","author":"Echart","year":"2012","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.vph.2013.05.001_bb0225","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1182\/blood.V100.1.334","article-title":"Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide","volume":"100","author":"Eissner","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.vph.2013.05.001_bb0230","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.autrev.2011.04.031","article-title":"Management of refractory cases of catastrophic antiphospholipid syndrome","volume":"10","author":"Espinosa","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.vph.2013.05.001_bb0235","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1055\/s-0038-1648519","article-title":"Defibrotide inhibits platelet activation by cathepsin G released from stimulated polymorphonuclear leukocytes","volume":"67","author":"Evangelista","year":"1992","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.vph.2013.05.001_bb0240","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0014-2999(92)90437-9","article-title":"Inhibition by heparin of platelet activation induced by neutrophil-derived cathepsin G","volume":"216","author":"Evangelista","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.vph.2013.05.001_bb0245","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1136\/bmj.318.7198.1606","article-title":"ABC of intensive care: organ dysfunction","volume":"318","author":"Evans","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.vph.2013.05.001_bb0250","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/sj.leu.2403004","article-title":"Defibrotide reduces procoagulant activity and increases fibrinolytic properties of endothelial cells","volume":"17","author":"Falanga","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.vph.2013.05.001_bb0255","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/00007890-199310000-00029","article-title":"Immunosuppressive effects of defibrotide","volume":"56","author":"Ferraresso","year":"1993","journal-title":"Transplantation"},{"key":"10.1016\/j.vph.2013.05.001_bb0270","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0168-8278(90)90056-W","article-title":"Prevention of impaired liver metabolism due to ischemia in rats. Efficacy of defibrotide administration","volume":"10","author":"Ferrero","year":"1990","journal-title":"J. Hepatol."},{"key":"10.1016\/j.vph.2013.05.001_bb0265","first-page":"251","article-title":"Efficacy of defibrotide treatment in favoring the function of the grafted heart and kidney in rats","volume":"26","author":"Ferrero","year":"1994","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.vph.2013.05.001_bb0260","doi-asserted-by":"crossref","first-page":"C1173","DOI":"10.1152\/ajpcell.2001.281.4.C1173","article-title":"Roles of tumor necrosis factor p55 and p75 receptors in TNF-alpha-induced vascular permeability","volume":"281","author":"Ferrero","year":"2001","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.vph.2013.05.001_bb0280","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0049-3848(93)90225-D","article-title":"Pharmacokinetics, absorption, distribution and disposition of [125I]-defibrotide following intravenous or oral administration in the rat","volume":"70","author":"Fisher","year":"1993","journal-title":"Thromb. Res."},{"key":"10.1016\/j.vph.2013.05.001_bb0275","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-3848(95)00213-8","article-title":"Study on pharmacokinetics of radioactive labelled defibrotide after oral or intravenous administration in rats","volume":"81","author":"Fisher","year":"1996","journal-title":"Thromb. Res."},{"key":"10.1016\/j.vph.2013.05.001_bb0285","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1126\/science.1172539","article-title":"Extending healthy life span \u2014 from yeast to humans","volume":"328","author":"Fontana","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.vph.2013.05.001_bb0290","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/SHK.0b013e3181c0f068","article-title":"Sepsis, leukocytes, and nitric oxide (NO): an intricate affair","volume":"33","author":"Fortin","year":"2010","journal-title":"Shock"},{"key":"10.1016\/j.vph.2013.05.001_bb0295","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1161\/ATVBAHA.111.240291","article-title":"Defibrotide interferes with several steps of the coagulation-inflammation cycle and exhibits therapeutic potential to treat severe malaria","volume":"32","author":"Francischetti","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2013.05.001_bb0300","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1161\/01.RES.58.6.783","article-title":"Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates","volume":"58","author":"Freiman","year":"1986","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2013.05.001_bb0305","first-page":"361","article-title":"Morphometric and ultrastructural study of experimental venous thrombosis. Effects of defibrotide, an antithrombotic agent","volume":"17","author":"Fumagalli","year":"1987","journal-title":"Haemostasis"},{"key":"10.1016\/j.vph.2013.05.001_bb0310","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1043-6618(89)80007-6","article-title":"Thrombolytic activity of defibrotide: a morphometric evaluation in experimental venous thrombosis","volume":"21","author":"Fumagalli","year":"1989","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.vph.2013.05.001_bb0315","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3390\/ijms9061008","article-title":"Effective DNA inhibitors of cathepsin g by in vitro selection","volume":"9","author":"Gatto","year":"2008","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.vph.2013.05.001_bb0320","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0049-3848(91)90273-Y","article-title":"Anticoagulant and antithrombotic effects of combinations of defibrotide with heparins and other antithrombotic agents in an animal thrombosis model","volume":"63","author":"Giedrojc","year":"1991","journal-title":"Thromb. Res."},{"key":"10.1016\/j.vph.2013.05.001_bb0325","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S1357-2725(98)00011-9","article-title":"Thrombin","volume":"30","author":"Goldsack","year":"1998","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.vph.2013.05.001_bb0330","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/378337a0","article-title":"Blood coagulation. The thrombin paradox","volume":"378","author":"Griffin","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.vph.2013.05.001_bb0335","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0031-6989(87)90115-9","article-title":"Defibrotide is equipotent to urokinase in stimulating arterial and venous thrombolysis","volume":"19","author":"Grodzinska","year":"1987","journal-title":"Pharmacol. Res. Commun."},{"key":"10.1016\/j.vph.2013.05.001_bb0340","first-page":"163","article-title":"Prostacyclin and the mechanism of action of defibrotide","volume":"2","author":"Gryglewski","year":"1989","journal-title":"Eicosanoids"},{"key":"10.1016\/j.vph.2013.05.001_bb0345","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","article-title":"Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor","volume":"8","author":"Guba","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.vph.2013.05.001_bb0350","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1517\/14712598.2012.657623","article-title":"Update on the use of defibrotide","volume":"12","author":"Guglielmelli","year":"2012","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.vph.2013.05.001_bb0355","series-title":"Signal Transduction Pathways by CpG-DNA","author":"Hacker","year":"2000"},{"key":"10.1016\/j.vph.2013.05.001_bb0360","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/hh0302.104724","article-title":"Regression of atherosclerosis in monkeys reduces vascular superoxide levels","volume":"90","author":"Hathaway","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2013.05.001_bb0365","first-page":"795","article-title":"Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III\/defibrotide therapy","volume":"91","author":"Haussmann","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.vph.2013.05.001_bb0370","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.4049\/jimmunol.164.4.2131","article-title":"Viral IL-10 gene transfer decreases inflammation and cell adhesion molecule expression in a rat model of venous thrombosis","volume":"164","author":"Henke","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.vph.2013.05.001_bb0380","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/00005344-199101000-00016","article-title":"Stimulation of prostacyclin synthesis by defibrotide: improved contractile recovery from myocardial \u201cstunning\u201d","volume":"17","author":"Hohlfeld","year":"1991","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.vph.2013.05.001_bb0375","first-page":"122","article-title":"Favourable effect of defibrotide in lipid A-induced shock in pigs","volume":"38","author":"Hohlfeld","year":"1992","journal-title":"Circ. Shock."},{"key":"10.1016\/j.vph.2013.05.001_bb0385","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0022-3565(25)10282-6","article-title":"Stimulation of endogenous prostacyclin protects the reperfused pig myocardium from ischemic injury","volume":"264","author":"Hohlfeld","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.vph.2013.05.001_bb0390","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1136\/bmj.316.7141.1328","article-title":"Endothelial cell activation. A central pathophysiological process","volume":"316","author":"Hunt","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.vph.2013.05.001_bb0395","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00024382-199801000-00002","article-title":"Proinflammatory cytokine gene expression in whole blood from patients undergoing coronary artery bypass surgery and its modulation by pentoxifylline","volume":"9","author":"Kleinschmidt","year":"1998","journal-title":"Shock"},{"key":"10.1016\/j.vph.2013.05.001_bb0400","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0049-3848(92)90054-E","article-title":"Acute t-PA release by defibrotide","volume":"66","author":"Klocking","year":"1992","journal-title":"Thromb. Res."},{"key":"10.1016\/j.vph.2013.05.001_bb0405","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00000658-198512000-00004","article-title":"Prognosis in acute organ-system failure","volume":"202","author":"Knaus","year":"1985","journal-title":"Ann. Surg."},{"key":"10.1016\/j.vph.2013.05.001_bb0410","doi-asserted-by":"crossref","first-page":"686","DOI":"10.4161\/cbt.6.5.3959","article-title":"Defibrotide: an endothelium protecting and stabilizing drug, has an anti-angiogenic potential in vitro and in vivo","volume":"6","author":"Koehl","year":"2007","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.vph.2013.05.001_bb0415","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1182\/blood-2010-01-264051","article-title":"Complement anaphylatoxin C5a contributes to hemodialysis-associated thrombosis","volume":"116","author":"Kourtzelis","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.vph.2013.05.001_bb0420","doi-asserted-by":"crossref","first-page":"12631","DOI":"10.1073\/pnas.95.21.12631","article-title":"Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs","volume":"95","author":"Krieg","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vph.2013.05.001_bb0425","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1750-3639.2000.tb00249.x","article-title":"Leukocyte recruitment and the acute inflammatory response","volume":"10","author":"Kubes","year":"2000","journal-title":"Brain Pathol."},{"key":"10.1016\/j.vph.2013.05.001_bb0435","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.RES.84.4.392","article-title":"Tumor necrosis factor-alpha contributes to ischemia- and reperfusion-induced endothelial activation in isolated hearts","volume":"84","author":"Kupatt","year":"1999","journal-title":"Circ. Res."},{"issue":"Suppl. 9","key":"10.1016\/j.vph.2013.05.001_bb0430","first-page":"96","article-title":"Endothelial activation \u2014 a strategic event during postischemic myocardial inflammation","volume":"89","author":"Kupatt","year":"2000","journal-title":"Z Kardiol"},{"key":"10.1016\/j.vph.2013.05.001_bb0440","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/BF00169738","article-title":"Coronary endothelium-protective effects of defibrotide in ischaemia and reperfusion","volume":"341","author":"Lefer","year":"1990","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.vph.2013.05.001_bb0445","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0008-6363(00)00247-9","article-title":"Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease","volume":"49","author":"Lefer","year":"2001","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2013.05.001_bb0450","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF00634228","article-title":"Selective stimulation of coronary vascular PGI2 but not of platelet thromboxane formation by defibrotide in the platelet perfused heart","volume":"331","author":"Lobel","year":"1985","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.vph.2013.05.001_bb0455","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0021-9150(89)90070-1","article-title":"Stimulation of vascular prostacyclin and inhibition of platelet function by oral defibrotide in cholesterol-fed rabbits","volume":"80","author":"Lobel","year":"1989","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.vph.2013.05.001_bb0460","first-page":"667","article-title":"Novel beneficial mechanisms of defibrotide, a prostacyclin enhancing agent in splanchnic artery occlusion and reperfusion in rats","volume":"13","author":"Ma","year":"1991","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.vph.2013.05.001_bb0465","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1357-4310(00)01814-1","article-title":"NF-kappaB as a therapeutic target in chronic inflammation: recent advances","volume":"6","author":"Makarov","year":"2000","journal-title":"Mol. Med. Today"},{"key":"10.1016\/j.vph.2013.05.001_bb0470","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1476-5381.1995.tb14978.x","article-title":"Polydeoxyribonucleotides and nitric oxide release from guinea-pig hearts during ischaemia and reperfusion","volume":"115","author":"Masini","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2013.05.001_bb0475","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1055\/s-0037-1616128","article-title":"Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation","volume":"86","author":"McEver","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.vph.2013.05.001_bb0480","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2013.05.001_bb0485","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1158\/1078-0432.CCR-08-1270","article-title":"Preclinical studies in support of defibrotide for the treatment of multiple myeloma and other neoplasias","volume":"15","author":"Mitsiades","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.vph.2013.05.001_bb0490","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1182\/blood.V87.2.642.bloodjournal872642","article-title":"Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats","volume":"87","author":"Murakami","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.vph.2013.05.001_bb0495","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.blre.2005.02.001","article-title":"Thrombotic thrombocytopenic purpura: aetiology, pathophysiology and treatment","volume":"20","author":"Murrin","year":"2006","journal-title":"Blood Rev."},{"key":"10.1016\/j.vph.2013.05.001_bb0500","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0049-3848(79)90141-5","article-title":"Plasminogen assay in rabbit, rat and mouse plasma using the chromogenic substrate s-2251","volume":"15","author":"Mussoni","year":"1979","journal-title":"Thromb. Res."},{"key":"10.1016\/j.vph.2013.05.001_bb0505","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0049-3848(81)90013-X","article-title":"Antithrombotic activity of a polydeoxyribonucleotidic substance extracted from mammalian organs: a possible link with prostacyclin","volume":"23","author":"Niada","year":"1981","journal-title":"Thromb. Res."},{"key":"10.1016\/j.vph.2013.05.001_bb0510","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0031-6989(82)80059-3","article-title":"PGI2-generation and antithrombotic activity of orally administered defibrotide","volume":"14","author":"Niada","year":"1982","journal-title":"Pharmacol. Res. Commun."},{"key":"10.1016\/j.vph.2013.05.001_bb0515","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0049-3848(85)90008-8","article-title":"Cardioprotective effects of defibrotide in acute myocardial ischemia in the cat","volume":"38","author":"Niada","year":"1985","journal-title":"Thromb. Res."},{"key":"10.1016\/j.vph.2013.05.001_bb0520","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0049-3848(86)90265-3","article-title":"Protective activity of defibrotide against lethal acute myocardial ischemia in the cat","volume":"42","author":"Niada","year":"1986","journal-title":"Thromb. Res."},{"key":"10.1016\/j.vph.2013.05.001_bb0525","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/00003495-199345020-00007","article-title":"Defibrotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders","volume":"45","author":"Palmer","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.vph.2013.05.001_bb0530","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bbmt.2010.11.019","article-title":"Defibrotide prevents the activation of macrovascular and microvascular endothelia caused by soluble factors released to blood by autologous hematopoietic stem cell transplantation","volume":"17","author":"Palomo","year":"2011","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.vph.2013.05.001_bb0535","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3324\/haematol.2009.017913","article-title":"Melphalan, prednisone, thalidomide and defibrotide in relapsed\/refractory multiple myeloma: results of a multicenter phase I\/II trial","volume":"95","author":"Palumbo","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.vph.2013.05.001_bb0540","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJM199305203282008","article-title":"Pathogenetic mechanisms of septic shock","volume":"328","author":"Parrillo","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2013.05.001_bb0545","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1161\/01.CIR.100.21.2124","article-title":"A tale of two diseases: atherosclerosis and rheumatoid arthritis","volume":"100","author":"Pasceri","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2013.05.001_bb0550","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1111\/j.1476-5381.1993.tb14002.x","article-title":"The effect of defibrotide on thromboembolism in the pulmonary vasculature of mice and rabbits and in the cerebral vasculature of rabbits","volume":"110","author":"Paul","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2013.05.001_bb0555","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1476-5381.1996.tb15427.x","article-title":"Drug-induced in vitro inhibition of neutrophil\u2013endothelial cell adhesion","volume":"118","author":"Pellegatta","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2013.05.001_bb0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/hh1301.093825","article-title":"Tissue factor, the emerging link between inflammation, thrombosis, and vascular remodeling","volume":"89","author":"Penn","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2013.05.001_bb0565","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1517\/14656566.1.6.1203","article-title":"Current treatment of sepsis and endotoxaemia","volume":"1","author":"Periti","year":"2000","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.vph.2013.05.001_bb0570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0049-3848(83)90391-2","article-title":"Pharmacokinetics of defibrotide and of its profibrinolytic activity in the rabbit","volume":"30","author":"Pescador","year":"1983","journal-title":"Thromb. Res."},{"key":"10.1016\/j.vph.2013.05.001_bb0575","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/0024-3205(89)90376-7","article-title":"Defibrotide decreases cholesterol amount in hypercholesterolemic rabbit aorta, with no modification of plasma or lipoprotein cholesterol","volume":"44","author":"Pescador","year":"1989","journal-title":"Life Sci."},{"key":"10.1016\/j.vph.2013.05.001_bb0580","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0024-3205(95)00308-S","article-title":"Effects of defibrotide on leukocytosis in rabbits with diet-induced atherosclerosis","volume":"57","author":"Pescador","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.vph.2013.05.001_bb0585","first-page":"68","article-title":"Leukotriene C4 disposition and metabolism in the anesthetized and endotoxemic dog","volume":"33","author":"Pfeifer","year":"1991","journal-title":"Circ. Shock."},{"key":"10.1016\/j.vph.2013.05.001_bb0590","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/01.RES.88.2.245","article-title":"Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin","volume":"88","author":"Pierangeli","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2013.05.001_bb0595","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1055\/s-2007-1002644","article-title":"Absorption through the peritoneum of the macromolecular profibrinolytic drug defibrotide in the rabbit","volume":"17","author":"Porta","year":"1991","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.vph.2013.05.001_bb0600","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0024-3205(94)00449-8","article-title":"Comparable beneficial effects of defibrotide and nifedipine in calcium induced atherosclerosis","volume":"54","author":"Porta","year":"1994","journal-title":"Life Sci."},{"key":"10.1016\/j.vph.2013.05.001_bb0605","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0014-2999(96)00885-0","article-title":"Hyperbaric oxygen worsens myocardial low flow ischemia\u2013reperfusion injury in isolated rat heart","volume":"320","author":"Radice","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.vph.2013.05.001_bb0610","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/hh0102.102795","article-title":"Molecular pathogenesis of the antiphospholipid syndrome","volume":"90","author":"Rand","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2013.05.001_bb0615","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1126\/science.1111726","article-title":"Latest advances in understanding preeclampsia","volume":"308","author":"Redman","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.vph.2013.05.001_bb0625","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood-2002-04-1216","article-title":"Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome","volume":"100","author":"Richardson","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.vph.2013.05.001_bb0630","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.bbmt.2010.02.009","article-title":"Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial","volume":"16","author":"Richardson","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.vph.2013.05.001_bb0620","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1517\/14740338.2012.749855","article-title":"Drug safety evaluation of defibrotide","volume":"12","author":"Richardson","year":"2013","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.vph.2013.05.001_bb0635","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/362801a0","article-title":"The pathogenesis of atherosclerosis: a perspective for the 1990s","volume":"362","author":"Ross","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.vph.2013.05.001_bb0640","doi-asserted-by":"crossref","first-page":"S419","DOI":"10.1016\/S0002-8703(99)70266-8","article-title":"Atherosclerosis is an inflammatory disease","volume":"138","author":"Ross","year":"1999","journal-title":"Am. Heart J."},{"key":"10.1016\/j.vph.2013.05.001_bb0665","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/00005344-199605000-00010","article-title":"Vasoconstriction to polymorphonuclear leukocytes in the isolated, perfused rabbit heart: inhibition by prostacyclin mimetics","volume":"27","author":"Rossoni","year":"1996","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.vph.2013.05.001_bb0645","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0049-3848(99)00009-2","article-title":"Chronic oral defibrotide counteracts hypercholesterolemia noxious effects on cardiovascular function in the rabbit","volume":"94","author":"Rossoni","year":"1999","journal-title":"Thromb. Res."},{"key":"10.1016\/j.vph.2013.05.001_bb0660","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1540-8191.1999.tb01005.x","article-title":"Protectant activity of defibrotide in cardioplegia followed by ischemia\/reperfusion injury in the isolated rat heart","volume":"14","author":"Rossoni","year":"1999","journal-title":"J. Card. Surg."},{"key":"10.1016\/j.vph.2013.05.001_bb0650","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0049-3848(99)00144-9","article-title":"Defibrotide normalizes cardiovascular function hampered by established atherosclerosis in the rabbit","volume":"97","author":"Rossoni","year":"2000","journal-title":"Thromb. Res."},{"key":"10.1016\/j.vph.2013.05.001_bb0655","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.phrs.2006.01.004","article-title":"Nitric oxide and prostacyclin pathways: an integrated mechanism that limits myocardial infarction progression in anaesthetized rats","volume":"53","author":"Rossoni","year":"2006","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.vph.2013.05.001_bb0675","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/01.bor.0000158150.57154.f9","article-title":"Vascular comorbidity in rheumatoid arthritis: potential mechanisms and solutions","volume":"17","author":"Sattar","year":"2005","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.vph.2013.05.001_bb0670","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","article-title":"Explaining how \u201chigh-grade\u201d systemic inflammation accelerates vascular risk in rheumatoid arthritis","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2013.05.001_bb0680","first-page":"669","article-title":"Effects of defibrotide on leukocyte-endothelial cell interaction in the rat mesenteric vascular bed: role of P-selectin","volume":"18","author":"Scalia","year":"1996","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.vph.2013.05.001_bb0685","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00024382-199609010-00004","article-title":"Time course of endothelial dysfunction and neutrophil adherence and infiltration during murine traumatic shock","volume":"6","author":"Scalia","year":"1996","journal-title":"Shock"},{"key":"10.1016\/j.vph.2013.05.001_bb0690","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.2042-7158.1995.tb05789.x","article-title":"Defibrotide protects endothelial cells, but not L929 tumour cells, from tumour necrosis factor-alpha-mediated cytotoxicity","volume":"47","author":"Schroder","year":"1995","journal-title":"J. Pharm. Pharmacol."},{"issue":"Suppl. 6","key":"10.1016\/j.vph.2013.05.001_bb0695","first-page":"35","article-title":"Endothelial protection by defibrotide \u2014 a new strategy for treatment of myocardial infarction?","volume":"78","author":"Schror","year":"1989","journal-title":"Z. Kardiol."},{"key":"10.1016\/j.vph.2013.05.001_bb0700","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4103\/0973-1482.59910","article-title":"Late-onset hepatic veno-occlusive disease post autologous peripheral stem cell transplantation successfully treated with oral defibrotide","volume":"5","author":"Shah","year":"2009","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.vph.2013.05.001_bb0705","first-page":"389","article-title":"Multiple organ dysfunction syndrome: end organ and systemic inflammatory response in a mouse model of nonseptic origin","volume":"4","author":"Shayevitz","year":"1995","journal-title":"Shock"},{"key":"10.1016\/j.vph.2013.05.001_bb0710","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1358\/mf.1998.20.6.485709","article-title":"Novel beneficial effects of defibrotide, an endothelium protecting agent, following ischemia and reperfusion in the isolated perfused rat heart","volume":"20","author":"Shin","year":"1998","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.vph.2013.05.001_bb0715","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/hep.1840190515","article-title":"Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms","volume":"19","author":"Shulman","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.vph.2013.05.001_bb0720","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/jlb.56.6.672","article-title":"Neutrophils, host defense, and inflammation: a double-edged sword","volume":"56","author":"Smith","year":"1994","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.vph.2013.05.001_bb0725","doi-asserted-by":"crossref","first-page":"e2010033","DOI":"10.4084\/mjhid.2010.033","article-title":"Thrombotic microangiopathy in haematopoietic cell transplantation: an update","volume":"2","author":"Stavrou","year":"2010","journal-title":"Mediterr. J. Hematol.Infect. Dis."},{"key":"10.1016\/j.vph.2013.05.001_bb0730","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1182\/blood.V87.4.1238.bloodjournal8741238","article-title":"Defects in hemostasis in P-selectin-deficient mice","volume":"87","author":"Subramaniam","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.vph.2013.05.001_bb0735","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.transproceed.2007.01.075","article-title":"Treatment of sinusoidal obstruction syndrome with defibrotide: a single-center experience","volume":"39","author":"Sucak","year":"2007","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.vph.2013.05.001_bb0740","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1161\/01.RES.0000171805.24799.fa","article-title":"Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines","volume":"96","author":"Szotowski","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2013.05.001_bb0745","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/sj.bmt.1702517","article-title":"Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome","volume":"26","author":"Takatsuka","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.vph.2013.05.001_bb0750","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/0024-3205(92)90565-7","article-title":"A novel insight into the mechanism of the antithrombotic action of defibrotide","volume":"51","author":"Tettamanti","year":"1992","journal-title":"Life Sci."},{"key":"10.1016\/j.vph.2013.05.001_bb0755","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/0002-9149(85)90416-3","article-title":"Usefulness of defibrotide in protecting ischemic myocardium from early reperfusion damage","volume":"56","author":"Thiemermann","year":"1985","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.vph.2013.05.001_bb0760","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1476-5381.1989.tb11967.x","article-title":"Defibrotide reduces infarct size in a rabbit model of experimental myocardial ischaemia and reperfusion","volume":"97","author":"Thiemermann","year":"1989","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2013.05.001_bb0765","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1161\/01.CIR.82.4.1402","article-title":"Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat","volume":"82","author":"Tsao","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2013.05.001_bb0770","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2013.05.001_bb0775","first-page":"827","article-title":"Lupus-associated endothelial dysfunction, disease activity and arteriosclerosis","volume":"26","author":"Valdivielso","year":"2008","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.vph.2013.05.001_bb0780","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/01.shk.0000196497.49683.13","article-title":"Leukocyte-endothelial interactions via ICAM-1 are detrimental in polymicrobial sepsis","volume":"25","author":"van Griensven","year":"2006","journal-title":"Shock"},{"key":"10.1016\/j.vph.2013.05.001_bb0785","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1055\/s-0037-1613890","article-title":"Improvement of walking distance by defibrotide in patients with intermittent claudication \u2014 results of a randomized, placebo-controlled study (the DICLIS study). Defibrotide Intermittent CLaudication Italian Study","volume":"83","author":"Violi","year":"2000","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.vph.2013.05.001_bb0790","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/01.RES.0000124302.20396.B7","article-title":"Reconstituted high-density lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of phosphatidylinositol 3-kinase but not Akt\/endothelial nitric oxide synthase","volume":"94","author":"Viswambharan","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2013.05.001_bb0800","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/01.ATV.15.2.258","article-title":"Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules","volume":"15","author":"Wakefield","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2013.05.001_bb0795","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0741-5214(00)90162-9","article-title":"Venous thrombosis prophylaxis by inflammatory inhibition without anticoagulation therapy","volume":"31","author":"Wakefield","year":"2000","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.vph.2013.05.001_bb0805","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM198902093200606","article-title":"Tissue destruction by neutrophils","volume":"320","author":"Weiss","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2013.05.001_bb0810","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1055\/s-0037-1614108","article-title":"Systemic endothelial cell markers in primary antiphospholipid syndrome","volume":"84","author":"Williams","year":"2000","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.vph.2013.05.001_bb0815","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1089\/hum.1998.9.10-1439","article-title":"The influence of DNA sequence on the immunostimulatory properties of plasmid DNA vectors","volume":"9","author":"Wloch","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.vph.2013.05.001_bb0820","first-page":"55","article-title":"Successful treatment with defibrotide for sinusoidal obstruction syndrome after hematopoietic stem cell transplantation","volume":"51","author":"Yakushijin","year":"2005","journal-title":"Kobe J. Med. Sci."},{"key":"10.1016\/j.vph.2013.05.001_bb0825","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0022-3565(24)38973-6","article-title":"Inhibition of endothelial cell activation by nitric oxide donors","volume":"295","author":"Zampolli","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.vph.2013.05.001_bb0830","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1055\/s-0038-1642468","article-title":"Defibrotide stimulates expression of thrombomodulin in human endothelial cells","volume":"71","author":"Zhou","year":"1994","journal-title":"Thromb. Haemost."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189113000700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189113000700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T09:54:36Z","timestamp":1746006876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189113000700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":166,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1537189113000700"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2013.05.001","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defibrotide: Properties and clinical use of an old\/new drug","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2013.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}